Fredun Pharmaceuticals P/B Ratio

Current P/B Ratio
7.1
High Valuation
Very High - Significant premium, high growth expectations or speculative

Fredun Pharmaceuticals P/B ratio. Fredun Pharmaceuticals (FREDUN) P/B ratio is 7.1 (High), book value per share ₹463.33 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. Read Fredun Pharmaceuticals dividend payments for the complete payout history and dividend yield track record.

Current Valuation Metrics

P/B Ratio 7.1
Current Price ₹1708.00
Book Value/Share ₹463.33
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹278 Cr
Share Capital ₹6 Cr
Reserves & Surplus ₹259 Cr
Outstanding Shares 6,000,000
Book Value per Share ₹463.33

Valuation Signal

Signal Overvalued
Historical Avg 4.64
Historical Range 3.69 - 5.6
Percentile 100.0%

Sector Context

Sector Average -0.3
Sector Median 0.39
Sector Rank #11 of 50
Sector Percentile 22.0%

FREDUN P/B Ratio — Valuation Insights & Book Value Analysis

Fredun Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 7.1 (High). For live price, earnings yield and the full fundamental profile, see FREDUN share price screener.

  • Stock appears overvalued with PB of 7.1, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 52.9% above historical average
  • Trading at premium to sector average PB of -0.3

Fredun Pharmaceuticals P/B Ratio Historical Trend

FREDUN annual price-to-book ratio — 2 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Browse Fredun Pharmaceuticals financial data for revenue, profit, balance sheet and cash flow data.

FREDUN Historical P/B Ratio — Book Value Per Share & Year-End Price

Fredun Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 3.69 ₹463.33 ₹1708.00 ₹278 High
2025 5.6 ₹282.0 ₹1578.30 ₹141 High

FREDUN vs Healthcare Peers — P/B Ratio Comparison

Fredun Pharmaceuticals P/B 7.1 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.

Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Chennai Meenakshi Multis… CMMHOSP -7.62 ₹27 Low
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -1.2 ₹39 Low
Krebs Biochemicals & Ind… KREBSBIO -0.75 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.18 ₹43 Low